TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
DHR

Danaher Corporation

Healthcare · Diagnostics & Research

211.80$ -0.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Danaher Corporation (DHR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 6,265 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size % Per share
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement DHR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
5,624 6,405 5,796 5,743 5,798 6,538 5,741 5,936 6,053 6,838 5,951 6,265 25,107
2,349 2,626 2,309 2,315 2,397 2,648 2,230 1,981 2,530 2,872 2,360 2,654 10,416
3,275 3,779 3,487 3,428 3,401 3,890 3,511 3,955 3,523 3,966 3,591 3,611 14,691
362 407 368 391 383 442 379 403 378 438 387 412 1,615
2,145 766 1,807 1,869 2,060 2,023 1,858 2,360 1,991 2,026 1,860 2,072 7,949
2,090 2,365 2,175 2,260 2,443 2,144 2,237 2,763 2,369 2,464 2,247 2,484 9,564
1,185 1,414 1,312 1,168 958 1,746 1,274 1,192 1,154 1,502 1,344 1,127 5,127
70 85 65 65 87 61 72 71 67 55 63 107 292
1,147 1,232 1,271 1,083 977 1,315 1,129 655 1,076 1,373 1,235 1,078 4,762
207 111 183 176 159 229 175 100 168 176 206 208 758
1,129 1,079 1,088 907 818 1,086 954 555 908 1,197 1,029 870 4,004
1,706 1,810 1,922 1,728 1,655 1,971 1,792 1,337 1,765 2,051 1,491 1,844 7,151

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?